Chandra Vargeese

3.7k citations

29 papers · 2.6k indexed · 1 hit paper · h-index 17

Co-authors: Shawn Zinnen Keith Bowman Barry Polisky Dylan Morrissey Jennifer A. Lockridge Karin S. Blanchard Kristi Jensen Lloyd B. Jeffs
Topics: Advanced biosensing and bioanalysis techniques (10 papers)RNA Interference and Gene Delivery (8 papers)DNA and Nucleic Acid Chemistry (6 papers)
Cited by: Molecular Biology Cancer Research Immunology
Journals: Nucleic Acids Research Nature Biotechnology Hepatology
Partner nations: United States United Kingdom Switzerland

In The Last Decade

Chandra Vargeese

29 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

2005 908 citations Dylan Morrissey, Jennifer A. Lockridge et al. Nature Biotechnology profile →

Peers

Countries citing papers authored by Chandra Vargeese

Since Specialization

Citations

This map shows the geographic impact of Chandra Vargeese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandra Vargeese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandra Vargeese more than expected).

Fields of papers citing papers by Chandra Vargeese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chandra Vargeese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandra Vargeese. The network helps show where Chandra Vargeese may publish in the future.

Co-authorship network of co-authors of Chandra Vargeese

This figure shows the co-authorship network connecting the top 25 collaborators of Chandra Vargeese. A scholar is included among the top collaborators of Chandra Vargeese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chandra Vargeese. Chandra Vargeese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical evaluation of WVE-004, an investigational stereopure oligonucleotide for the treatment of C9orf72-associated ALS or FTD 2022 ·Molecular Therapy — Nucleic Acids ·Yuanjing Liu,Amy Andreucci,Naoki Iwamoto,Yuan Yin,Hailin Yang,Fangjun Liu,(unknown),Xiao Hu,(unknown),Sarah D. Lamore,(unknown),Susovan Mohapatra,Erin Purcell-Estabrook,(unknown),Elena Dale,Chandra Vargeese	36
2	WVE-004, an investigational stereopure antisense oligonucleotide for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) (2302) 2021 ·Neurology ·Yuanjing Liu,Amy Andreucci,Naoki Iwamoto,Yuan Yin,Hailin Yang,Fangjun Liu,(unknown),Susovan Mohapatra,Erin Purcell-Estabrook,(unknown),Elena Dale,Chandra Vargeese	5
3	Stereochemistry Enhances Potency, Efficacy, and Durability of Malat1 Antisense Oligonucleotides In Vitro and In Vivo in Multiple Species 2021 ·Translational Vision Science & Technology ·Michael Byrne,Vinod Vathipadiekal,Luciano H. Apponi,Naoki Iwamoto,Kandasamy Pachamuthu,Kenneth Longo,Fangjun Liu,Richard Looby,(unknown),(unknown),Juili Dilip Shelke,Chikdu Shivalila,Hailin Yang,Yuan Yin,Lankai Guo,Keith Bowman,Chandra Vargeese	19
4	Investigational Assay for Haplotype Phasing of the Huntingtin Gene 2020 ·Molecular Therapy — Methods & Clinical Development ·Nenad Svrzikapa,Kenneth Longo,Nripesh Prasad,(unknown),Jeffrey M. Brown,Daniel C. Dorset,Scott Yourstone,Jason Powers,Shawn Levy,Aaron J. Morris,Chandra Vargeese,Jaya Goyal	12
5	Stereopure Oligonucleotides for the Selective Silencing of Mutant Huntingtin (4703) 2020 ·Neurology ·Elena Dale,Maria Frank-Kamenetsky,(unknown),(unknown),Yuanjing Liu,(unknown),Jeffrey M. Brown,Kandasamy Pachamuthu,(unknown),(unknown),Naoki Iwamoto,Yuan Yin,Hailin Yang,Stephany M. Standley,(unknown),Kenneth Longo,Michael Byrne,Chandra Vargeese	4
6	Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides 2017 ·Nature Biotechnology ·Naoki Iwamoto,David C. Butler,Nenad Svrzikapa,Susovan Mohapatra,Ivan Zlatev,Dinah W.Y. Sah,Meena Meena,Stephany M. Standley,Genliang Lu,Luciano H. Apponi,Maria Frank-Kamenetsky,(unknown),Chandra Vargeese,Gregory L. Verdine	263
7	Preclinical studies of WVE-210201, an investigational stereopure antisense oligonucleotide in development for the treatment of patients with duchenne muscular dystrophy (DMD) 2017 ·Journal of the Neurological Sciences ·Michael Panzara,(unknown),Carlo Rinaldi,Graham McClorey,Keith Bowman,David Butler,Jean‐Cosme Dodart,Maria Frank-Kamenetsky,Naoki Iwamoto,(unknown),Genliang Lu,(unknown),(unknown),(unknown),Shruti Menon,Stephany M. Standley,H. T. Yang,Zhirong Zhong,Matthew J. A. Wood,Chandra Vargeese	1
8	WVE-210201, an investigational stereopure oligonucleotide therapy for Duchenne muscular dystrophy, induces Exon 51 skipping and dystrophin protein restoration 2017 ·Neuromuscular Disorders ·Matthew J. A. Wood,(unknown),Keith Bowman,David Butler,Carlo Rinaldi,Graham McClorey,Maria Frank-Kamenetsky,Naoki Iwamoto,(unknown),Genliang Lu,(unknown),Mahesh Chand Meena,Shruti Menon,Mamoru Shimizu,Stephany M. Standley,Hailin Yang,Zhiwei Zhong,Christopher Francis,Chandra Vargeese	4
9	Biodistribution and Metabolism Studies of Lipid Nanoparticle–Formulated Internally [3H]-Labeled siRNA in Mice 2014 ·Drug Metabolism and Disposition ·(unknown),(unknown),Thomas Faller,Esther van de Kerkhof,François Natt,Jürg Hunziker,(unknown),Iwan Beuvink,Keith Bowman,Jeremy L. Baryza,(unknown),Chandra Vargeese,Olivier Heudi,Markus Stoeckli,Joel A. Krauser,Piet Swart	43
10	Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes 2009 ·American Journal of Physiology-Endocrinology and Metabolism ·Maziyar Saberi,(unknown),Simon Schenk,Takeshi Imamura,Gautam Bandyopadhyay,Pingping Li,(unknown),Chandra Vargeese,Weimin Wang,Keith Bowman,Ye Zhang,Barry Polisky,Jerrold M. Olefsky	62
11	Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1 2005 ·Gene Therapy ·Jikui Shen,(unknown),(unknown),Hideo Akiyama,(unknown),Yoshitsugu Saishin,Sean F. Hackett,Shawn Zinnen,Karl Kossen,Kathy Fosnaugh,Chandra Vargeese,(unknown),Karyn Bouhana,(unknown),P A Pavco,Peter A. Campochiaro	236
12	Potent and persistent in vivo anti-HBV activity of chemically modified siRNAsbreakdown → 2005 ·Nature Biotechnology ·Dylan Morrissey,Jennifer A. Lockridge,(unknown),Karin S. Blanchard,Kristi Jensen,(unknown),(unknown),(unknown),Susan F. Radka,Vasant Jadhav,Narendra K. Vaish,Shawn Zinnen,Chandra Vargeese,Keith Bowman,(unknown),Lloyd B. Jeffs,Adam D. Judge,Ian MacLachlan,Barry Polisky	908
13	Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication† 2005 ·Hepatology ·Dylan Morrissey,Karin S. Blanchard,(unknown),Kristi Jensen,Jennifer A. Lockridge,Brent Dickinson,James A. McSwiggen,Chandra Vargeese,Keith Bowman,(unknown),Barry Polisky,Shawn Zinnen	219
14	Characterization of nuclease‐resistant ribozymes directed against hepatitis B virus RNA* 2002 ·Journal of Viral Hepatitis ·Dylan Morrissey,(unknown),David A. Johnson,(unknown),James A. McSwiggen,Leonid Beigelman,(unknown),Lara Maloney,Chandra Vargeese,Keith Bowman,(unknown),(unknown),Andrew Conrad,Peter Schmid,John D. Morrey,Dennis G. Macejak,P A Pavco,Lawrence M. Blatt	19
15	Novel Approach to Specific Growth Factor Inhibition in Vivo 1999 ·American Journal Of Pathology ·Jürgen Floege,Tammo Ostendorf,Ulf Janssen,Michael Burg,Heinfried H. Radeke,Chandra Vargeese,Stanley C. Gill,Louis S. Green,Nebojša Janjić	193
16	Efficient activation of nucleoside phosphoramidites with 4,5- dicyanoimidazole during oligonucleotide synthesis 1998 ·Nucleic Acids Research ·Chandra Vargeese	107
17	2‘-Amino-2‘-deoxyuridine via an Intramolecular Cyclization of a Trichloroacetimidate 1996 ·The Journal of Organic Chemistry ·D. P. C. MCGEE,(unknown),Chandra Vargeese,Yansheng Zhai	64
18	Efficient Synthesis of 2′-Amino-2′-deoxypyrimidine 5′-Triphosphates 1995 ·Nucleosides and Nucleotides ·D. P. C. MCGEE,Chandra Vargeese,Yansheng Zhai,Gary P. Kirschenheuter,(unknown),(unknown),Wolfgang A. Pieken	15
19	Potent 2'-Amino-2'-deoxypyrimidine RNA Inhibitors of Basic Fibroblast Growth Factor 1995 ·Biochemistry ·Derek Jellinek,Louis S. Green,Carol Bell,(unknown),(unknown),Chandra Vargeese,Gary P. Kirschenheuter,(unknown),(unknown)	171
20	Adenosine Deaminase Inhibitors. Synthesis and Biological Evaluation of Putative Metabolites of (+)-erythro-9-(2S-Hydroxy-3R-nonyl)adenine 1994 ·Journal of Medicinal Chemistry ·Chandra Vargeese,(unknown),(unknown),Elie Abushanab,(unknown),Johanna D. Stoeckler	16

About Chandra Vargeese

Chandra Vargeese is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience, having authored 29 papers that have together received 2.6k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (10 papers), RNA Interference and Gene Delivery (8 papers) and DNA and Nucleic Acid Chemistry (6 papers). The work is most often cited by research in Molecular Biology (2.2k citations), Cancer Research (468 citations) and Immunology (246 citations). Chandra Vargeese has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Shawn Zinnen, Keith Bowman, Barry Polisky, Dylan Morrissey, Jennifer A. Lockridge, Karin S. Blanchard, Kristi Jensen, Lloyd B. Jeffs, Narendra K. Vaish and Susan F. Radka. Their work appears in journals such as Nucleic Acids Research, Nature Biotechnology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact